Cancer Center Lineup complete: 11 Renewals, Funding Continued for Three, Two Unfunded
In Brief: Lame Ducks continue On NCAB; Calabresi Elected To IOM; Ravikumar Moves To Yale
NCI Study Finds No Greater Cancer Risk Near Nuclear Plants
NCI Should Examine Alternative Therapies TA Report Says
NCI Advisory Group, Other Cancer Meetings For Oct., Nov., Future
Trending Stories
- Karen Knudsen to leave ACS
- A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies - Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Tumors are able to form with no DNA mutations, fly study shows
- From clinician scientist to nonprofit CEO